RxDoctor Payments Data

Heith Waddell, MD

Family Medicine · Custer, SDNPI 1932413267

Payments from drug & device makers

$587in general payments, 2019–2025

Across 30 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$275
  • Amgen$91
  • Teleflex LLC$58
  • Sanofi-aventis U.S. LLC$54
  • AstraZeneca$38
  • Johnson & Johnson$25
  • plus $46 from 3 others

What the payments were for

  • Food & beverage$45878%
  • Education$12922%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$587 in reported general payments places this provider in the 70th percentile of 408 family medicine providers in South Dakota.

See all family medicine providers in South Dakota

Medicare billing

Part B allowed, 2024
$3,714
Medicare patients
24
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban124$122,583
Tresiba Flextouch U-200Insulin Degludec58$62,084
OzempicSemaglutide50$52,823
TrulicityDulaglutide40$37,878
JardianceEmpagliflozin23$22,084
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,920
Breo ElliptaFluticasone/Vilanterol16$6,213
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$3,125
Novolin NInsulin Nph Human Isophane12$2,984
Levothyroxine Sodium230$2,882
Losartan Potassium171$2,186
Metoprolol Succinate82$2,072
Tamsulosin Hcl85$1,902
Atorvastatin Calcium210$1,858
Gabapentin81$1,781

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$275$52,82350 claims
Lilly USA, LLCTrulicity$16$37,87840 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 408 family medicine providers in South Dakota.

Other family medicine in Custer

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →